公告日期：2017-04-29

辅仁药业集团实业股份有限公司审 计 报 告瑞华审字[2017]41100007号目 录一、 审计报告 ··········································································· 1二、 已审财务报表1、 合并资产负债表 ································································· 32、 合并利润表 ······································································· 53、 合并现金流量表 ································································· 64、 合并股东权益变动表 ·························································· 75、 资产负债表 ······································································· 96、 利润表 ············································································· 117、 现金流量表 ······································································· 128、 股东权益变动表································································· 139、 财务报表附注 ··································································· 15通讯地址：北京市东城区永定门西滨河路8号院7号楼中海地产广场西塔5-11层PostalAddress:5-11/F,WestTowerofChinaOverseasPropertyPlaza,Building7,NO.8,YongdingmenXibinheRoad,DongchengDistrict,Beijing邮政编码（PostCode）：100077电话（Tel）： 86(10)88095588 传真（Fax）： 86(10)88091199审计报告瑞华审字[2017]41100007号辅仁药业集团实业股份有限公司全体股东：我们审计了后附的辅仁药业集团实业股份有限公司（以下简称“辅仁药业”）的财务报表，包括2016年12月31日合并及公司的资产负债表，2016年度合并及公司的利润表、合并及公司的现金流量表和合并及公司的股东权益变动表以及财务报表附注。一、管理层对财务报表的责任编制和公允列报财务报表是辅仁药业管理层的责任。这种责任包括：（1）按照企业会计准则的规定编制财务报表，并使其实现公允反映；（2）设计、执行和维护必要的内部控制，以使财务报表不存在由于舞弊或错误导致的重大错报。二、注册会计师的责任我们的责任是在执行审计工作的基础上对财务报表发表审计意见。我们按照中国注册会计师审计准则的规定执行了审计工作。中国注册会计师审计准则要求我们遵守中国注册会计师职……[点击查看原文][查看历史公告]

提示：本网不保证其真实性和客观性，一切有关该股的有效信息，以交易所的公告为准，敬请投资者注意风险。

声明：如本站内容不慎侵犯了您的权益，请联系邮箱：wangshiyuan@epins.cn 我们将迅速删除。